Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
9,801
-1,749
-15% -$173K 0.01% 917
2026
Q1
$1.09M Sell
11,550
-34,212
-75% -$3.41M 0.01% 845
2025
Q4
$4.52M Buy
45,762
+4,080
+10% +$395K 0.04% 355
2025
Q3
$3.54M Buy
41,682
+38,320
+1,140% +$3.03M 0.03% 395
2025
Q2
$229K Buy
+3,362
New +$213K ﹤0.01% 1443
2024
Q3
– Sell
-17,574
Closed -$1.07M – 1474
2024
Q2
$1.07M Buy
+17,574
New +$995K 0.03% 575

Other funds holding INCY

Vident Advisory's INCY Position: Q2 2026 in Review

Vident Advisory reduced its Incyte (INCY) stake by 15% in Q2 2026, selling an estimated $173K and leaving 9,801 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #917.

Vident Advisory first reported a position in INCY in Q2 2024 and has held it in 6 quarters since. The position peaked at $4.52M in Q4 2025. 861 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Vident Advisory held 9,801 shares of Incyte worth $1.11M as of Q2 2026.
  • Vident Advisory sold 1,749 Incyte shares in Q2 2026, an estimated $173K.
  • Incyte made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #917 holding.
  • Vident Advisory first reported a position in Incyte in Q2 2024 and has held it in 6 quarters since.
  • Vident Advisory's Incyte position peaked at $4.52M in Q4 2025.
  • 861 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.